SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease.
CardioVascular Research Foundation Asan Medical Center Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety.
Endeavor IV-A Randomized Comparison of a Zotarolimus-Eluting Stent Endeavor IV-A Randomized Comparison of a Zotarolimus-Eluting Stent
Martin B. Leon, MD for the Endeavor IV investigators Columbia University Medical Center Cardiovascular Research Foundation New York City Monday, September.
Management of Coronary Artery Disease: Saravanan Kuppuswamy MD Division of Cardiology Department of Internal Medicine University of Missouri Hospital.
M.Unverdorben; TCT 2007 1 Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.
The Science Behind Taxus Advanced Angioplasty 2004 Christian Vander Velde, Boston Scientific Europe, Marketing.
ACC/AHA Guidelines STEMI
Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting.
The Science Behind Taxus